ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OXF Oxford Technology 4 Venture Capital Trust Plc

34.00
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Technology 4 Venture Capital Trust Plc LSE:OXF London Ordinary Share GB00B01H4V84 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Oxford Tech 4 VCT 3rd Quarter Results

17/12/2018 7:00am

UK Regulatory


 
TIDMOXF 
 
 
 
   Oxford Technology 4 VCT Plc 
 
   Update for the quarter ending 30 November 2018 
 
   Oxford Technology 4 VCT Plc presents its quarterly update for the period 
commencing 1 September 2018. 
 
   The Directors have recently reviewed the valuation of its entire 
portfolio as at 30 November 2018. 
 
   The unaudited net asset value per ordinary share (NAV) as at 30 November 
2018 was 46.5p.  This is a fall of 2.1p from the previously published 
NAV for the period ending 31 August 2018. The fall in NAV is primarily 
due to the Castleton bid price falling (101p to 95p) and the valuation 
of Zuvasyntha being reduced to zero. It was offset by a small increase 
in Orthogem's valuation. 
 
   The total return to shareholders including previous dividends of 40.0p 
per share is now 86.5p per share. 
 
   During the quarter, a sale of Castleton shares was made (disposal 
proceeds of GBP30K) and Abzena shareholders accepted a cash takeover 
(disposal proceeds GBP15k). Glide was dissolved, and the liquidation of 
Historic Futures completed (neither of these had any effect on the NAV 
as both investments had already been fully provided for). Follow on 
investments were made in Orthogem (GBP79k) and Arecor (GBP99k). 
Zuvasyntha closed when it became clear that they would not be able to 
accept a major Innovate grant that they had won due to Innovate's 
changed interpretation of EU State Aid rules. 
 
   The total number of ordinary shares in issue is 11,516,946. 
 
   The Directors are not aware of any other events or transactions which 
have taken place between 30 November 2018 and the publication of this 
statement which have had a material effect on the financial position of 
the Company. 
 
   17 December 2018 
 
   Enquiries: 
 
   Lucius Cary, Oxford Technology Management 
 
   01865 784466 
 
 
 
 
 
 

(END) Dow Jones Newswires

December 17, 2018 02:00 ET (07:00 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year Oxford Technology 4 Vent... Chart

1 Year Oxford Technology 4 Vent... Chart

1 Month Oxford Technology 4 Vent... Chart

1 Month Oxford Technology 4 Vent... Chart

Your Recent History

Delayed Upgrade Clock